NewsVandana Singh
AC Immune SA
ACIU · NASDAQ
$2.49+$0.055 (+2.26%)TodayMarket closed ·
Prev close $2.44
Latest news
- NewsVandana Singh
AC Immune Says Early Data from Anti-Inflammatory Drug Gives Wider Clinical Momentum for Pipeline
- Press releaseGlobe Newswire
AC Immune Receives FDA Fast Track Designation for Anti-Alpha-synuclein Active Immunotherapy, ACI-7104, to Treat Early Parkinson’s Disease (PD)
- Press releaseGlobe Newswire
AC Immune First Half 2026 Financial and Corporate Update
- Press releaseGlobe Newswire
AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer’s Disease
- News
AC Immune Announces It Dosed The First Patients In Cohort AD4 In The Ongoing Phase 1b/2 ABATE Trial
- Press releaseGlobe Newswire
AC Immune First Quarter 2026 Financial and Corporate Updates
- Press releaseGlobe Newswire
AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's Disease
- NewsAvi Kapoor
FGI Industries, Nouveau Monde Graphite And Other Big Stocks Moving Lower In Friday's Pre-Market Session
- News
AC Immune Amended Its 2018 Agreement With Eli Lilly For Tau Aggregation Inhibitor Drugs For Alzheimer's And Other Neurodegenerative Diseases, AC Immune Will Receive CHF10M
- Press releaseGlobe Newswire
AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly
- Press releaseGlobe Newswire
AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate Update
- News
AC Immune Q3 EPS $(0.20) Beats $(0.22) Estimate, Sales $1.174M Miss $1.520M Estimate
- Press releaseGlobe Newswire
AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
- Press releaseGlobe Newswire
AC Immune Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
- News
'FDA Clears First Blood Test Used In Diagnosing Alzheimer's Disease; New Test Provides Less Invasive Option, Reduces Reliance On Pet Scans And Increases Diagnosis Accessibility' - FDA
- Press releaseGlobe Newswire
AC Immune Reports First Quarter 2025 Financial Results and Provides a Corporate Update
- NewsAvi Kapoor
S&P 500 Moves Lower; US Crude Oil Inventories Increase
- NewsAvi Kapoor
Hillenbrand Posts Better-Than-Expected Earnings, Joins Beazer Homes, Tapestry, Walt Disney And Other Big Stocks Moving Higher On Thursday
- News
AC Immune Q3 EPS $0.06 Beats $(0.23) Estimate, Sales $29.44M Beat $1.74M Estimate
- Press releaseGlobe Newswire
AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
- NewsAvi Kapoor
Why Granite Point Mortgage Trust Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.